» Articles » PMID: 3907901

Complement Fixation by Pemphigus Antibody. II. Complement Enhanced Detachment of Epidermal Cells

Overview
Date 1985 Sep 1
PMID 3907901
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously demonstrated that pemphigus antibodies will fix complement to organ and tissue cultured epidermal cells in vitro. In the present study, we sought to determine the role complement plays in the detachment of cultured murine epidermal cells by pemphigus antibody. Forty-eight hour cultivated epidermal monolayers from neonatal BALB/c mice were treated with purified IgG fractions of pemphigus sera in the presence or absence of complement. In the absence of complement, pemphigus IgG produced slight cell detachment when compared to an identical amount of normal IgG. When cells were maintained in media with pemphigus IgG plus complement for 48 h, the cell detachment was significantly higher than that obtained with pemphigus IgG alone, or with normal IgG plus complement. Heat inactivation or Clq depletion of the complement source resulted in complete inhibition of cell detachment. When pemphigus F(ab')2 plus complement was used instead of whole pemphigus IgG plus complement, the cell detachment rate was again lowered significantly. Both pemphigus IgG and the complement source were depleted of plasminogen by passage over a lysine-Sepharose 4B column, and tested for their effects on cell detachment depleted of plasminogen. Depletion of plasminogen failed to inhibit cell detachment induced by pemphigus IgG and complement. These results suggest that complement activated by pemphigus antibody binding to the epidermal cell surface induces epidermal cell detachment and would argue against the plasminogen-plasmin system as the sole cause of cell detachment in pemphigus.

Citing Articles

Sparking Fire Under the Skin? Answers From the Association of Complement Genes With Pemphigus Foliaceus.

Bumiller-Bini V, Adelman Cipolla G, Coutinho de Almeida R, Petzl-Erler M, Augusto D, Boldt A Front Immunol. 2018; 9:695.

PMID: 29686679 PMC: 5900433. DOI: 10.3389/fimmu.2018.00695.


Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.

Eyre R, Stanley J J Clin Invest. 1988; 81(3):807-12.

PMID: 3343340 PMC: 442529. DOI: 10.1172/JCI113387.


Subclass distribution of human IgG autoantibodies in pemphigus.

Jones C, Hamilton R, Jordon R J Clin Immunol. 1988; 8(1):43-9.

PMID: 3284896 DOI: 10.1007/BF00915155.


Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Stanley J J Clin Invest. 1989; 83(5):1443-8.

PMID: 2651476 PMC: 303845. DOI: 10.1172/JCI114036.


Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.

Xia P, Jordon R, Geoghegan W J Clin Invest. 1988; 82(6):1939-47.

PMID: 2461964 PMC: 442775. DOI: 10.1172/JCI113813.


References
1.
SAMS Jr W, Schur P . Studies of the antibodies in pemphigoid and pemphigus. J Lab Clin Med. 1973; 82(2):249-54. View

2.
Jordan R, Day N, Luckasen J, GOOD R . Complement activation in pemphigus vulgaris blister fluid. Clin Exp Immunol. 1973; 15(1):53-63. PMC: 1553867. View

3.
March S, Parikh I, Cuatrecasas P . A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem. 1974; 60(1):149-52. DOI: 10.1016/0003-2697(74)90139-0. View

4.
Jordon R, Schroeter A, Rogers 3rd R, PERRY H . Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol. 1974; 63(3):256-9. DOI: 10.1111/1523-1747.ep12680098. View

5.
Jordon R, MCDUFFIE F . Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies. Proc Soc Exp Biol Med. 1976; 151(3):594-8. DOI: 10.3181/00379727-151-39267. View